{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:19:43Z","timestamp":1781709583848,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T00:00:00Z","timestamp":1543017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40659-018-0199-y","type":"journal-article","created":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T06:48:07Z","timestamp":1543042087000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2"],"prefix":"10.1186","volume":"51","author":[{"given":"Feng","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,24]]},"reference":[{"key":"199_CR1","doi-asserted-by":"publisher","first-page":"19328","DOI":"10.18632\/oncotarget.2896","volume":"6","author":"F Galdiero","year":"2015","unstructured":"Galdiero F, Romano A, Pasquinelli R, Pignata S, Greggi S, Vuttariello E, Bello AM, Calise C, Scaffa C, Pisano C, Losito NS, Fusco A, Califano D, Chiappetta G. Detection of high mobility group a2 specific mrna in the plasma of patients affected by epithelial ovarian cancer. Oncotarget. 2015;6:19328\u201335.","journal-title":"Oncotarget"},{"key":"199_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10\u201329.","journal-title":"CA Cancer J Clin"},{"key":"199_CR3","first-page":"586","volume":"14","author":"L Hutchinson","year":"2017","unstructured":"Hutchinson L. Targeted therapies: Solo2 confirms olaparib maintenance in ovarian cancer. Nat Rev Clin Oncol. 2017;14:586\u20137.","journal-title":"Nat Rev Clin Oncol"},{"key":"199_CR4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nrc2271","volume":"7","author":"A Fusco","year":"2007","unstructured":"Fusco A, Fedele M. Roles of hmga proteins in cancer. Nat Rev Cancer. 2007;7:899\u2013910.","journal-title":"Nat Rev Cancer"},{"key":"199_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2008.11.026","volume":"135","author":"SM Hammond","year":"2008","unstructured":"Hammond SM, Sharpless NE. Hmga2, micrornas, and stem cell aging. Cell. 2008;135:1013\u20136.","journal-title":"Cell"},{"key":"199_CR6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.canlet.2016.04.005","volume":"376","author":"J Wu","year":"2016","unstructured":"Wu J, Zhang S, Shan J, Hu Z, Liu X, Chen L, Ren X, Yao L, Sheng H, Li L, Ann D, Yen Y, Wang J, Wang X. Elevated hmga2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer. Cancer Lett. 2016;376:284\u201392.","journal-title":"Cancer Lett"},{"key":"199_CR7","doi-asserted-by":"crossref","first-page":"25872","DOI":"10.18632\/oncotarget.8288","volume":"7","author":"A Palumbo Jr","year":"2016","unstructured":"Palumbo A Jr, Da Costa NM, Esposito F, De Martino M, D\u2019Angelo D, de Sousa VP, Martins I, Nasciutti LE, Fusco A, Ribeiro Pinto LF. Hmga2 overexpression plays a critical role in the progression of esophageal squamous carcinoma. Oncotarget. 2016;7:25872\u201384.","journal-title":"Oncotarget"},{"key":"199_CR8","doi-asserted-by":"crossref","first-page":"21825","DOI":"10.18632\/oncotarget.7989","volume":"7","author":"C Fan","year":"2016","unstructured":"Fan C, Lin Y, Mao Y, Huang Z, Liu AY, Ma H, Yu D, Maitikabili A, Xiao H, Zhang C, Liu F, Luo Q, Ouyang G. Microrna-543 suppresses colorectal cancer growth and metastasis by targeting kras, mta1 and hmga2. Oncotarget. 2016;7:21825\u201339.","journal-title":"Oncotarget"},{"key":"199_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/carcin\/bgw029","volume":"37","author":"J Wu","year":"2016","unstructured":"Wu J, Wang Y, Xu X, Cao H, Sahengbieke S, Sheng H, Huang Q, Lai M. Transcriptional activation of fn1 and il11 by hmga2 promotes the malignant behavior of colorectal cancer. Carcinogenesis. 2016;37:511\u201321.","journal-title":"Carcinogenesis"},{"key":"199_CR10","doi-asserted-by":"publisher","first-page":"21554","DOI":"10.18632\/oncotarget.15795","volume":"8","author":"A Agostini","year":"2017","unstructured":"Agostini A, Brunetti M, Davidson B, Trope CG, Heim S, Panagopoulos I, Micci F. Genomic imbalances are involved in mir-30c and let-7a deregulation in ovarian tumors: implications for hmga2 expression. Oncotarget. 2017;8:21554\u201360.","journal-title":"Oncotarget"},{"key":"199_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2174\/138920101505140828161335","volume":"15","author":"Y Tutar","year":"2014","unstructured":"Tutar Y. Mirna and cancer; computational and experimental approaches. Curr Pharm Biotechnol. 2014;15:429.","journal-title":"Curr Pharm Biotechnol"},{"issue":"Suppl 2","key":"199_CR12","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1038\/onc.2009.353","volume":"27","author":"P Trang","year":"2008","unstructured":"Trang P, Weidhaas JB, Slack FJ. Micrornas as potential cancer therapeutics. Oncogene. 2008;27(Suppl 2):S52\u20137.","journal-title":"Oncogene"},{"key":"199_CR13","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.3892\/or.2015.4168","volume":"34","author":"J Cheng","year":"2015","unstructured":"Cheng J, Deng R, Zhang P, Wu C, Wu K, Shi L, Liu X, Bai J, Deng M, Shuai X, Gao J, Wang G, Tao K. Mir-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene sall4. Oncol Rep. 2015;34:1923\u201332.","journal-title":"Oncol Rep"},{"key":"199_CR14","first-page":"9032502","volume":"2017","author":"J Long","year":"2017","unstructured":"Long J, Menggen Q, Wuren Q, Shi Q, Pi X. Mir-219-5p inhibits the growth and metastasis of malignant melanoma by targeting bcl-2. Biomed Res Int. 2017;2017:9032502.","journal-title":"Biomed Res Int"},{"key":"199_CR15","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3892\/or.2015.4120","volume":"34","author":"J Wu","year":"2015","unstructured":"Wu J, Lai M, Shao C, Wang J, Wei JJ. Stc2 overexpression mediated by hmga2 is a biomarker for aggressiveness of high-grade serous ovarian cancer. Oncol Rep. 2015;34:1494\u2013502.","journal-title":"Oncol Rep"},{"key":"199_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan N, Swanton C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell. 2017;168:613\u201328.","journal-title":"Cell"},{"key":"199_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.lfs.2017.10.007","volume":"191","author":"L Qiu","year":"2017","unstructured":"Qiu L, Tang Q, Li G, Chen K. Long non-coding rnas as biomarkers and therapeutic targets: recent insights into hepatocellular carcinoma. Life Sci. 2017;191:273\u201382.","journal-title":"Life Sci"},{"key":"199_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gene.2017.09.012","volume":"637","author":"C Wei","year":"2017","unstructured":"Wei C, Zhang X, He S, Liu B, Han H, Sun X. Microrna-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the twist\/wnt\/beta-catenin signaling pathway. Gene. 2017;637:25\u201332.","journal-title":"Gene"},{"key":"199_CR19","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00109-013-1055-8","volume":"91","author":"J Wu","year":"2013","unstructured":"Wu J, Wei JJ. Hmga2 and high-grade serous ovarian carcinoma. J Mol Med (Berl). 2013;91:1155\u201365.","journal-title":"J Mol Med (Berl)"},{"key":"199_CR20","first-page":"53","volume":"229","author":"D Califano","year":"2014","unstructured":"Califano D, Pignata S, Losito NS, Ottaiano A, Greggi S, De Simone V, Cecere S, Aiello C, Esposito F, Fusco A, Chiappetta G. High hmga2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer. J Cell Physiol. 2014;229:53\u20139.","journal-title":"J Cell Physiol"},{"key":"199_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/odi.12608","volume":"23","author":"H Zhang","year":"2017","unstructured":"Zhang H, Tang Z, Deng C, He Y, Wu F, Liu O, Hu C. Hmga2 is associated with the aggressiveness of tongue squamous cell carcinoma. Oral Dis. 2017;23:255\u201364.","journal-title":"Oral Dis"},{"key":"199_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.abb.2016.09.007","volume":"610","author":"Q Zou","year":"2016","unstructured":"Zou Q, Wu H, Fu F, Yi W, Pei L, Zhou M. Rkip suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of mir-185 targeting hmga2. Arch Biochem Biophys. 2016;610:25\u201332.","journal-title":"Arch Biochem Biophys"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-018-0199-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40659-018-0199-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-018-0199-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T23:04:09Z","timestamp":1605481449000},"score":1,"resource":{"primary":{"URL":"https:\/\/biolres.biomedcentral.com\/articles\/10.1186\/s40659-018-0199-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,24]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["199"],"URL":"https:\/\/doi.org\/10.1186\/s40659-018-0199-y","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,24]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"50"}}